Entera Bio (ENTX) EPS (Diluted) (2019 - 2026)
Entera Bio (ENTX) EPS (Diluted) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.15 |
| 10 | Entera Bio | 165.23 Mn | 153.92 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.13 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.11 |